IRIS UniCatt

Daniele, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.016
AS - Asia 5.730
EU - Europa 4.705
SA - Sud America 1.549
AF - Africa 265
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 4
Totale 18.289
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.798
SG - Singapore 2.491
CN - Cina 1.284
IT - Italia 1.284
BR - Brasile 1.233
DE - Germania 990
VN - Vietnam 699
SE - Svezia 646
FR - Francia 436
IE - Irlanda 280
GB - Regno Unito 219
ID - Indonesia 210
IN - India 185
JP - Giappone 184
UA - Ucraina 174
FI - Finlandia 169
AR - Argentina 148
RU - Federazione Russa 148
HK - Hong Kong 137
CI - Costa d'Avorio 113
BD - Bangladesh 86
MX - Messico 85
CA - Canada 83
PL - Polonia 77
TR - Turchia 75
IQ - Iraq 71
KR - Corea 50
ES - Italia 49
NL - Olanda 48
ZA - Sudafrica 48
AT - Austria 46
EC - Ecuador 41
PK - Pakistan 36
VE - Venezuela 33
BE - Belgio 31
CO - Colombia 31
SA - Arabia Saudita 25
UZ - Uzbekistan 21
AU - Australia 20
TW - Taiwan 20
JO - Giordania 19
PE - Perù 19
TN - Tunisia 18
MA - Marocco 15
NP - Nepal 15
CL - Cile 14
EG - Egitto 14
AE - Emirati Arabi Uniti 13
IR - Iran 13
KE - Kenya 13
IL - Israele 12
JM - Giamaica 12
MY - Malesia 12
PH - Filippine 12
PT - Portogallo 12
PY - Paraguay 12
RO - Romania 12
AZ - Azerbaigian 11
CZ - Repubblica Ceca 11
RS - Serbia 11
UY - Uruguay 11
DO - Repubblica Dominicana 10
DZ - Algeria 10
ET - Etiopia 9
LB - Libano 9
CH - Svizzera 8
AL - Albania 7
LT - Lituania 7
BO - Bolivia 6
GR - Grecia 6
NO - Norvegia 6
SN - Senegal 6
BA - Bosnia-Erzegovina 5
HN - Honduras 5
OM - Oman 5
PS - Palestinian Territory 5
BG - Bulgaria 4
HR - Croazia 4
KZ - Kazakistan 4
PA - Panama 4
QA - Qatar 4
AM - Armenia 3
AO - Angola 3
BH - Bahrain 3
BY - Bielorussia 3
DK - Danimarca 3
GT - Guatemala 3
LK - Sri Lanka 3
MD - Moldavia 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
BZ - Belize 2
CG - Congo 2
CY - Cipro 2
EU - Europa 2
GA - Gabon 2
NG - Nigeria 2
SO - Somalia 2
TM - Turkmenistan 2
Totale 18.258
Salva come PNG Salva come JPEG
Città #
Singapore 1.212
San Jose 724
Ashburn 651
Chandler 623
Beijing 272
Dublin 258
Ho Chi Minh City 244
Hanoi 181
Jakarta 173
Lauterbourg 172
Tokyo 168
Hefei 160
Rome 153
Hong Kong 123
Milan 123
San Mateo 123
Wilmington 123
New York 119
Los Angeles 115
Abidjan 113
Jacksonville 112
Nanjing 109
Dallas 107
Boston 105
São Paulo 105
Dearborn 102
Cambridge 97
Princeton 94
Frankfurt am Main 92
Ann Arbor 90
Helsinki 80
St Louis 79
Moscow 78
Council Bluffs 74
Cattolica 66
Woodbridge 64
Redwood City 61
Warsaw 61
Fairfield 60
Seattle 50
The Dalles 49
Chicago 48
Nürnberg 48
Houston 47
Kent 46
Nuremberg 44
Seoul 42
Munich 41
Rio de Janeiro 41
Nanchang 39
Naples 39
Da Nang 38
Redmond 35
Shanghai 34
Boardman 33
Chennai 33
Lawrence 33
Marseille 33
Paris 33
Santa Clara 33
London 32
Buffalo 31
Brooklyn 30
Guangzhou 30
Shenyang 29
Atlanta 28
Bari 27
Bremen 27
Curitiba 27
Izmir 27
Brasília 26
Norwalk 26
Turku 26
Changsha 25
Orem 25
Baghdad 24
Hangzhou 24
Belo Horizonte 23
Montreal 23
Mountain View 23
Brussels 22
Vienna 21
Amsterdam 20
Campinas 20
Kunming 20
Tianjin 20
Amman 19
Dhaka 19
Lappeenranta 19
Biên Hòa 18
Johannesburg 18
Mexico City 18
Haiphong 17
Hebei 17
Tashkent 17
Denver 16
Lancaster 16
Phoenix 16
Stockholm 16
Istanbul 15
Totale 9.202
Salva come PNG Salva come JPEG
Nome #
Neuropsichiatria dei disturbi dell’umore. In: Neuroscienze cliniche e del comportamento. Basi neurobiologiche e neuropsicologiche. Psicopatologia funzionale e neuropsichiatria A cura di C. Blundo 577
Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease 365
Basi neuro anatomiche delle funzioni cognitive e del comportamento 244
Unilateral Extradural Motor Cortex Stimulation is Safe and Improves Parkinson's Disease at 1 Year 221
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants 206
Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease 203
Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review 200
Extradural motor cortex stimulation improves gait, speech, and language in a patient with pure akinesia 192
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 190
Sexual Behavior in Women with Bipolar Disorder 186
Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation 173
Effects of COVID-19 Lockdown on Movement Disorders Patients With Deep Brain Stimulation: A Multicenter Survey 169
New insights into the genetic etiology of Alzheimer's disease and related dementias 165
Sensorial frailty: age-related hearing loss and the risk of cognitive impairment and dementia in later life 164
Role of CLU, PICALM, and TNK1 Genotypes in Aging With and Without Alzheimer's Disease 161
Oxidative Stress And Overexpression Of Manganese Superoxide Dismutase In Patients With Alzheimer's Disease. 160
Extradural Motor Cortex Stimulation in Parkinson's Disease: Long-Term Clinical Outcome. 160
Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention 157
Extradural Motor Cortex Stimulation might improve episodic and working memory in patients with Parkinson’s disease 155
Additive Role of a Potentially Reversible Cognitive Frailty Model and Inflammatory State on the Risk of Disability: The Italian Longitudinal Study on Aging. 154
Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry 151
High frequency extradural motor cortex stimulation transiently improves axial symptoms in a patient with Parkinson's disease 150
Analysis of blink rate in patients with blepharospasm 141
Suicidal behaviour in older age: A systematic review of risk factors associated to suicide attempts and completed suicides 140
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease? 139
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores 139
Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson’s disease: Need for long-term trials. 138
Effects of deep brain stimulation of the subthalamic nucleus on patients with Parkinson's disease: a machine-learning voice analysis 137
APOE epsilon 2/epsilon 4 genotype a risk factor for primary progressive aphasia in women 136
Polymorphism C in the serotonin 1 transporter gene in depression-free elderly patients with vascular dementia 136
Oral frailty and its determinants in older age: a systematic review 136
Contribution of Mediterranean Diet in the Prevention of Alzheimer's Disease. 134
Disproportionate Impairment in Naming and Comprehension of Nouns with Relative Sparing of Verbs in a Patient who Survived Herpes Simplex Encephalitis 133
Cognitive and behavioural changes after deep brain stimulation of the subthalamic nucleus in Parkinson’s disease 132
Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy 130
The potential of solanezumab and gantenerumab to prevent Alzheimerâ s disease in people with inherited mutations that cause its early onset 130
Psychotropic drugs and CYP2D6 in late-life psychiatric and neurological disorders. What do we know? 129
Can a Positive Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients with Parkinson's Disease? The Potential Role of Zolpidem in the Treatment of Parkinson's Disease 128
Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2) 128
An Old Challenge with New Promises: A Systematic Review on Comprehensive Geriatric Assessment in Long-Term Care Facilities 126
Neuropsychological features of patients with Parkinson’s disease and impulse control disorders 123
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease 123
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease 123
Social Frailty in the COVID-19 Pandemic Era 122
Reversible Cognitive Frailty, Dementia, and All-Cause Mortality. The Italian Longitudinal Study on Aging 121
Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients 120
Neuroanatomical Correlates of Category-specific Semantic Disorders: A Critical Survey 120
Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease 120
Accelerated Long-Term Forgetting Limited to the Recollection Component of Recognition Memory in a Temporal Lobe Epileptic Patient 119
The RELN locus in Alzheimer's Disease 116
Italian Frontotemporal Dementia Network (FTD Group-SINDEM): sharing clinical and diagnostic procedures in Frontotemporal Dementia in Italy 115
Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy 114
Apolipoprotein E ε4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients 111
Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial 110
Early rightwards orienting of attention on simple reaction time performance in patients with left-sided neglect 108
Clusters of cognitive and behavioral disorders clearly distinguish primary progressive aphasia from frontal lobe dementia, and Alzheimer's disease 108
Does the imbalance in the apolipoprotein E isoforms underlie the pathophysiological process of sporadic Alzheimer's disease? 108
Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease 107
Tau-directed approaches for the treatment of Alzheimers disease: Focus on leuco-methylthioninium 106
Freezing of gait in Parkinson's disease: the paradoxical interplay between gait and cognition 105
Nutritional Intervention as a Preventive Approach for Cognitive-Related Outcomes in Cognitively Healthy Older Adults: A Systematic Review 105
Early visual memory deficits: a neuropsychological marker of GBA mutations in PD? 103
Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease 103
Biopsychosocial frailty and the risk of incident dementia: The Italian longitudinal study on aging 102
The missing ApoE allele 101
Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs 101
The pharmacogenetic road to avoid adverse drug reactions and therapeutic failures in revolving door patients with psychiatric illnesses: focus on the CYP2D6 isoenzymes 101
Malattia di Parkinson e altri disordini del movimento 101
Tau-based therapeutics for Alzheimer's disease: Active and passive immunotherapy 100
Cognitive frailty: a potential target for secondary prevention of dementia 100
Cognitive frailty: definitions, components, and impact on disability and mortality 100
Spinal cord stimulation may improve gait and cognition in hereditary spastic paraplegia with mental retardation: a case report 98
Intraoperative Local Field Potential Beta Power and Three-Dimensional Neuroimaging Mapping Predict Long-Term Clinical Response to Deep Brain Stimulation in Parkinson Disease: A Retrospective Study 97
Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease 97
FOXP2, APOE, and PRNP: New Modulators in Primary Progressive Aphasia 97
Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease 97
Genotypes and haplotypes in the IL-1 gene cluster: Analysis of two genetically and diagnostically distinct groups of Alzheimer patients 97
ALZT-OP1: an experimental combination regimen for the treatment of Alzheimer's disease 96
TOMM40, APOE, and APOC1 in Primary Progressive Aphasia and Frontotemporal Dementia 96
The role of biomarkers in psychiatry 96
Development of disease-modifying drugs for frontotemporal dementia spectrum disorders 96
Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs 96
Alzheimer disease risk associated with APOE4 is modified by STH gene polymorphism 95
Pharmacotherapy for the treatment of depression in patients with alzheimer’s disease: a treatment-resistant depressive disorder 94
The need of an extensive neuropsychological assessment for a reliable diagnosis of mild cognitive impairment in patients with Parkinson's disease 91
Physical Frailty, Multimorbidity, and All-Cause Mortality in an Older Population From Southern Italy: Results from the Salus in Apulia Study 91
Zolpidem in Parkinson's disease 90
APOE ε2-ε4 genotype is a possible risk factor for primary progressive aphasia [6] 89
Functional disorders after COVID-19 vaccine fuel vaccination hesitancy 89
The diagnostic accuracy of late-life depression is influenced by subjective memory complaints and educational level in an older population in Southern Italy 89
Oral frailty indicators and cardio- and cerebrovascular diseases in older age: A systematic review 88
Normal pressure hydrocephalus 88
Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation 87
Psychiatry meets pharmacogenetics for the treatment of revolving door patients with psychiatric disorders 86
Corrigendum to "Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review" Neurosci. Biobehav. Rev. 95 (2018) 480-498 86
Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer's disease? 86
Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke 84
Methylenetetrahydrofolate reductase and angiotensin converting enzyme gene polymorphisms in two genetically and diagnostically distinct cohort of Alzheimer patients 84
Clinical Indicators of Oral Frailty: A Domain-specific Frailty Phenotype 84
The relationship between epigenetics and microbiota in neuropsychiatric diseases 83
Totale 12.978
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.882
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.882
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021100 0 0 0 0 0 0 0 0 0 0 65 35
2021/20221.095 80 73 31 71 112 51 28 151 65 53 172 208
2022/20232.086 229 235 170 227 181 258 187 145 249 72 62 71
2023/20241.315 72 362 61 61 75 124 117 51 32 46 147 167
2024/20252.690 56 54 197 105 146 106 75 133 433 277 607 501
2025/20268.198 1.260 267 748 1.198 1.150 400 1.263 500 598 743 71 0
Totale 18.857